大博医疗
(002901)
| 流通市值：131.05亿 | | | 总市值：188.13亿 |
| 流通股本：2.88亿 | | | 总股本：4.14亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 641,496,893.47 | 2,600,859,747.67 | 1,876,254,824.66 | 1,210,439,721.5 |
| 营业总成本 | 460,125,572.77 | 1,948,789,556.99 | 1,409,952,460.92 | 905,711,853.76 |
| 其他经营收益 | | | | |
| 营业利润 | 184,655,056.67 | 737,643,633.29 | 514,358,734.98 | 298,665,072.61 |
| 利润总额 | 184,334,673.88 | 730,044,229.92 | 514,344,347.22 | 298,738,262.54 |
| 净利润 | 161,890,303.88 | 636,878,732.12 | 448,823,669.3 | 259,239,024.54 |
| 每股收益 | | | | |
| 其他综合收益 | -708,649.52 | 57,287.36 | 385,712.63 | 465,507.78 |
| 综合收益总额 | 161,181,654.36 | 636,936,019.48 | 449,209,381.93 | 259,704,532.32 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,458,092,373.84 | 3,339,109,889.32 | 2,986,575,438.17 | 2,784,683,782.56 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,571,515,288.21 | 1,585,113,724.46 | 1,568,264,095.58 | 1,578,969,446.97 |
| 资产总计 | 5,029,607,662.05 | 4,924,223,613.78 | 4,554,839,533.75 | 4,363,653,229.53 |
| 流动负债: | | | | |
| 流动负债合计 | 817,229,542.67 | 878,175,977.13 | 792,212,769.64 | 870,723,255.32 |
| 非流动负债: | | | | |
| 非流动负债合计 | 357,802,029.1 | 360,806,651.34 | 325,178,099.15 | 259,967,303.29 |
| 负债合计 | 1,175,031,571.77 | 1,238,982,628.47 | 1,117,390,868.79 | 1,130,690,558.61 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,724,409,492.94 | 3,570,001,649.26 | 3,336,569,852.45 | 3,143,123,526.25 |
| 股东权益合计 | 3,854,576,090.28 | 3,685,240,985.31 | 3,437,448,664.96 | 3,232,962,670.92 |
| 负债和股东权益合计 | 5,029,607,662.05 | 4,924,223,613.78 | 4,554,839,533.75 | 4,363,653,229.53 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 701,823,212.6 | 3,051,935,304.31 | 2,125,257,418.09 | 1,331,170,420.63 |
| 经营活动现金流出小计 | 631,467,660.31 | 2,220,598,266.52 | 1,656,965,370.04 | 1,068,334,314.45 |
| 经营活动产生的现金流量净额 | 70,355,552.29 | 831,337,037.79 | 468,292,048.05 | 262,836,106.18 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 676,513,457.55 | 1,679,332,924.26 | 1,286,199,342.72 | 933,107,760.28 |
| 投资活动现金流出小计 | 838,110,416.9 | 2,358,991,236.97 | 1,605,258,126.37 | 1,030,340,789.98 |
| 投资活动产生的现金流量净额 | -161,596,959.35 | -679,658,312.71 | -319,058,783.65 | -97,233,029.7 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 50,000,000 | 147,996,677 | 77,570,176 | 4,871,776 |
| 筹资活动现金流出小计 | 7,845,404.33 | 421,905,968.9 | 416,557,201.69 | 316,201,611.05 |
| 筹资活动产生的现金流量净额 | 42,154,595.67 | -273,909,291.9 | -338,987,025.69 | -311,329,835.05 |
| 汇率变动对现金及现金等价物的影响 | -1,153,284.08 | 5,712,041.89 | 5,369,109.23 | 5,724,848.6 |
| 现金及现金等价物净增加额 | -50,240,095.47 | -116,518,524.93 | -184,384,652.06 | -140,001,909.97 |
| 期末现金及现金等价物余额 | 77,757,994.05 | 127,998,089.52 | 60,131,962.39 | 104,514,704.48 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -116,518,524.93 | - | -140,001,909.97 |